{"id":1843,"date":"2022-02-07T18:49:29","date_gmt":"2022-02-07T17:49:29","guid":{"rendered":"https:\/\/glycanostics.com\/?p=1843"},"modified":"2022-07-08T08:37:59","modified_gmt":"2022-07-08T06:37:59","slug":"glykoprofilacia-prostatickeho-specifickeho-antigenu-ako-diagnosticky-a-prognosticky-biomarker-rakoviny-prostaty","status":"publish","type":"post","link":"https:\/\/glycanostics.com\/sk\/glykoprofilacia-prostatickeho-specifickeho-antigenu-ako-diagnosticky-a-prognosticky-biomarker-rakoviny-prostaty\/","title":{"rendered":"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1843\" class=\"elementor elementor-1843\">\n\t\t\t\t\t\t\t\t\t<section data-particle_enable=\"false\" data-particle-mobile-disabled=\"false\" class=\"elementor-section elementor-top-section elementor-element elementor-element-63d18135 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"63d18135\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-dc73ed3\" data-id=\"dc73ed3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c32bc53 elementor-widget elementor-widget-heading\" data-id=\"c32bc53\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-538f657c elementor-widget elementor-widget-text-editor\" data-id=\"538f657c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\tThe initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, thereby considerably reducing the number of unnecessary biopsies. In addition, PSA glycoprofiling can serve as a prognostic PCa biomarker to identify PCa patients with an aggressive form of PCa, avoiding unnecessary further treatments which are significantly life altering (incontinence or impotence).\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[25],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty - Glycanostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty - Glycanostics\" \/>\n<meta property=\"og:description\" content=\"The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077\" \/>\n<meta property=\"og:site_name\" content=\"Glycanostics\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-07T17:49:29+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-08T06:37:59+00:00\" \/>\n<meta name=\"author\" content=\"cagan@seesame.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Autor\" \/>\n\t<meta name=\"twitter:data1\" content=\"cagan@seesame.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 min\u00fata\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077\",\"url\":\"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077\",\"name\":\"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty - Glycanostics\",\"isPartOf\":{\"@id\":\"https:\/\/glycanostics.com\/#website\"},\"datePublished\":\"2022-02-07T17:49:29+00:00\",\"dateModified\":\"2022-07-08T06:37:59+00:00\",\"author\":{\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d\"},\"breadcrumb\":{\"@id\":\"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glycanostics.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glycanostics.com\/#website\",\"url\":\"https:\/\/glycanostics.com\/\",\"name\":\"Glycanostics\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glycanostics.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d\",\"name\":\"cagan@seesame.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/glycanostics.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g\",\"caption\":\"cagan@seesame.com\"},\"url\":\"https:\/\/glycanostics.com\/sk\/author\/caganseesame-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty - Glycanostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077","og_locale":"sk_SK","og_type":"article","og_title":"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty - Glycanostics","og_description":"The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, [&hellip;]","og_url":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077","og_site_name":"Glycanostics","article_published_time":"2022-02-07T17:49:29+00:00","article_modified_time":"2022-07-08T06:37:59+00:00","author":"cagan@seesame.com","twitter_card":"summary_large_image","twitter_misc":{"Autor":"cagan@seesame.com","Predpokladan\u00fd \u010das \u010d\u00edtania":"1 min\u00fata"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077","url":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077","name":"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty - Glycanostics","isPartOf":{"@id":"https:\/\/glycanostics.com\/#website"},"datePublished":"2022-02-07T17:49:29+00:00","dateModified":"2022-07-08T06:37:59+00:00","author":{"@id":"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d"},"breadcrumb":{"@id":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsfs.2018.0077#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glycanostics.com\/"},{"@type":"ListItem","position":2,"name":"Glykoprofil\u00e1cia prostatick\u00e9ho \u0161pecifick\u00e9ho antig\u00e9nu ako diagnostick\u00fd a prognostick\u00fd biomarker rakoviny prostaty"}]},{"@type":"WebSite","@id":"https:\/\/glycanostics.com\/#website","url":"https:\/\/glycanostics.com\/","name":"Glycanostics","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glycanostics.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/badee4cbfc54e0bf99314635b428c54d","name":"cagan@seesame.com","image":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/glycanostics.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7849fc5f0186381f2497fdb687e3b6dd?s=96&d=mm&r=g","caption":"cagan@seesame.com"},"url":"https:\/\/glycanostics.com\/sk\/author\/caganseesame-com\/"}]}},"_links":{"self":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/1843"}],"collection":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/comments?post=1843"}],"version-history":[{"count":1,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/1843\/revisions"}],"predecessor-version":[{"id":1844,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/posts\/1843\/revisions\/1844"}],"wp:attachment":[{"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/media?parent=1843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/categories?post=1843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glycanostics.com\/sk\/wp-json\/wp\/v2\/tags?post=1843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}